Literature DB >> 15279688

Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans.

Sara J Knight1, Amy K Siston, Joan S Chmiel, Nicholas Slimack, Arthur S Elstein, Gretchen B Chapman, Robert B Nadler, Charles L Bennett.   

Abstract

Ethnic variations that may influence the preferences and outcomes associated with prostate cancer treatment are not well delineated. Our objective was to evaluate prospectively preferences, optimism, involvement in care, and quality of life (QOL) in black and white veterans newly diagnosed with localized prostate cancer. A total of 95 men who identified themselves as black/African-American or white who had newly diagnosed, localized prostate cancer completed a "time trade-off" task to assess utilities for current health and mild, moderate, and severe functional impairment; importance rankings for attributes associated with prostate cancer (eg, urinary function); and baseline and follow-up measures of optimism, involvement in care, and QOL. Interviews were scheduled before treatment, and at 3 and 12 months after treatment. At baseline, both blacks and whites ranked pain, bowel, and bladder function as their most important concerns. Optimism, involvement in care, and QOL were similar. Utilities for mild impairment were lower for blacks than whites, but were similar for moderate and severe problems. Decline in QOL at 3 and 12 months compared to baseline occurred for both groups. However, even with adjustment for marital status, education level, and treatment, blacks had less increase in nausea and vomiting and more increase in difficulty with sexual interest and weight gain compared with whites. Black and white veterans entered localized prostate cancer treatment with similar priorities, optimism, and involvement in care. Quality-of-life declines were common to both groups during the first year after diagnosis, but ethnic variation occurred with respect to nausea and vomiting, sexual interest, and weight gain.

Entities:  

Mesh:

Year:  2004        PMID: 15279688     DOI: 10.3816/cgc.2004.n.010

Source DB:  PubMed          Journal:  Clin Prostate Cancer        ISSN: 1540-0352


  9 in total

1.  Racial differences in well-being and cancer concerns in prostate cancer patients.

Authors:  Sumedha Chhatre; Alan J Wein; S Bruce Malkowicz; Ravishankar Jayadevappa
Journal:  J Cancer Surviv       Date:  2011-01-28       Impact factor: 4.442

2.  A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment.

Authors:  Leslie R Schover; Andrea L Canada; Ying Yuan; Dawen Sui; Leah Neese; Rosell Jenkins; Michelle M Rhodes
Journal:  Cancer       Date:  2011-09-26       Impact factor: 6.860

3.  Can differences in breast cancer utilities explain disparities in breast cancer care?

Authors:  Mark D Schleinitz; Dina DePalo; Jeffrey Blume; Michael Stein
Journal:  J Gen Intern Med       Date:  2006-09-01       Impact factor: 5.128

Review 4.  Racial and ethnic disparities in the VA health care system: a systematic review.

Authors:  Somnath Saha; Michele Freeman; Joahd Toure; Kimberly M Tippens; Christine Weeks; Said Ibrahim
Journal:  J Gen Intern Med       Date:  2008-02-27       Impact factor: 5.128

5.  Factors associated with time-to-treatment of prostate cancer in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Georges Adunlin; Askal Ali; Youjie Huang; Clement K Gwede
Journal:  J Health Care Poor Underserved       Date:  2013-11

6.  Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer.

Authors:  M T King; R Viney; D P Smith; I Hossain; D Street; E Savage; S Fowler; M P Berry; M Stockler; P Cozzi; P Stricker; J Ward; B K Armstrong
Journal:  Br J Cancer       Date:  2012-01-24       Impact factor: 7.640

Review 7.  Quality of Life Among Black Prostate Cancer Survivors: An Integrative Review.

Authors:  Sabrina L Dickey; Motolani E Ogunsanya
Journal:  Am J Mens Health       Date:  2018-06-21

8.  Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities.

Authors:  Salimah H Meghani; Christopher S Lee; Alexandra L Hanlon; Deborah W Bruner
Journal:  BMC Med Inform Decis Mak       Date:  2009-11-27       Impact factor: 2.796

9.  Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions.

Authors:  Bashir Al Hussein Al Awamlh; Neal Patel; Xiaoyue Ma; Adam Calaway; Lee Ponsky; Jim C Hu; Jonathan E Shoag
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.